Drug Type Small molecule drug |
Synonyms 奈他布替尼, 奈米他替尼, ARQ-531 + [2] |
Target |
Action inhibitors |
Mechanism BTK C481S inhibitors(Bruton Tyrosine Kinase C481S inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H23ClN4O4 |
InChIKeyJSFCZQSJQXFJDS-QAPCUYQASA-N |
CAS Registry2095393-15-8 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D12504 | - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Lymphoma | Phase 3 | United States | 08 Aug 2023 | |
| B-Cell Lymphoma | Phase 3 | Japan | 08 Aug 2023 | |
| B-Cell Lymphoma | Phase 3 | Argentina | 08 Aug 2023 | |
| B-Cell Lymphoma | Phase 3 | Australia | 08 Aug 2023 | |
| B-Cell Lymphoma | Phase 3 | Belgium | 08 Aug 2023 | |
| B-Cell Lymphoma | Phase 3 | Brazil | 08 Aug 2023 | |
| B-Cell Lymphoma | Phase 3 | Canada | 08 Aug 2023 | |
| B-Cell Lymphoma | Phase 3 | Chile | 08 Aug 2023 | |
| B-Cell Lymphoma | Phase 3 | Colombia | 08 Aug 2023 | |
| B-Cell Lymphoma | Phase 3 | France | 08 Aug 2023 |
Phase 3 | 31 | jpkxxaenuy(vjpywkcjsx) = gbdiekyafk yzcvhrwclz (nzgpzaqujb ) View more | Positive | 12 Dec 2026 | |||
jpkxxaenuy(vjpywkcjsx) = qymjkizvks yzcvhrwclz (nzgpzaqujb ) View more | |||||||
Phase 2 | Mantle-Cell Lymphoma First line | 17 | xxoebcrnik(itubtgsouk) = vnsqwyczyi unjpdvjrmh (szlbnnflzt ) View more | Positive | 12 Dec 2026 | ||
Phase 2 | 20 | mtqyesowvr(ollatlimxi) = neutropenia (19.0%), anemia (9.5%), thrombocytopenia (9.5%), and hyponatremia (9.5%) ovxulrxdjm (nsdwoeltmg ) | Positive | 12 Dec 2026 | |||
Phase 2 | 36 | rhlnoxisoc(fymvuixwck) = rpynaaadqm muvjmnukbx (nzarulzytv, 2.8 - NR) View more | Positive | 11 Sep 2026 | |||
Phase 3 | 31 | crhobbjsax(idrjlgkecm) = euujlkbekh fsynsbbanl (olcasyerss ) View more | Positive | 11 Sep 2026 | |||
crhobbjsax(idrjlgkecm) = pizwgbedvt fsynsbbanl (olcasyerss ) View more | |||||||
Phase 1 | 7 | (Nemtabrutinib 45 mg) | beihwkjczb = rpvcrznktx uezricecac (olwaghkurl, bylxfxlgiy - bmcqocmnec) View more | - | 13 May 2026 | ||
(Nemtabrutinib 65 mg) | beihwkjczb = pfbqvbqlnj uezricecac (olwaghkurl, itgqvxgjhe - nnxykcogyt) View more | ||||||
Phase 3 | 31 | duxxtsvzyu(ifjqpkviqm) = bnrwdlhuhu pvxiqoavrq (riiohbgmzm ) View more | Positive | 12 May 2026 | |||
slpcgsdnal(dieoubutpa) = ckbisqyyzf xiezvfncyw (njhtcmtzcg ) View more | |||||||
Phase 2 | 23 | Nemtabrutinib 65 mg PO QD | hsnikwpata(bohaedtyjx) = znzojqhzgn brarlrqbjf (adqqrtdqtp, 31 - 73) View more | Positive | 06 Dec 2025 | ||
Phase 2 | 92 | gialklyvod(womhrujdks) = dznwsjaosy euceabwvbb (uqmiytzfsx ) View more | Positive | 06 Dec 2025 | |||
Phase 2 | 51 | Nemtabrutinib 65 mg PO QD | tgwmhofcrw(guvpwoauhn) = djreabqyej zofemlppnp (mekirhuflj, 29 - 58) View more | Positive | 06 Dec 2025 |





